|Day Low/High||194.56 / 200.56|
|52 Wk Low/High||144.27 / 209.18|
We initiated two new positions, raised Nvidia's price target and downgraded First Data.
Jim Cramer tackles the volatility issue and outlines the game plan for next week.
Defense stocks are on the move after the U.S. government ups its defense budgets.
We have three conditions that must be met before we would be buyers today.
Brian Goldner, chairman and CEO at toymaker Hasbro, tells Jim Cramer about strong growth in their franchise brands and partnerships.
Benno Dorer, chairman and CEO of The Clorox Co., tells Jim Cramer about anticipated benefits from tax reform.
Jim Cramer highlights Target, Triton, Covanta, and Corcept Therapeutics.
Jim Cramer says fundamentals of a stock matter less than the mechanics of how this market works. Investors need to be able to handle this kind of volatility.
Jim discusses this morning's buy of Nordstrom, Allergan's earnings from yesterday and his view on a few upcoming earning reports.
Since last Tuesday, we effectively replaced what we sold for new buys, avoiding some of the large swoon in stocks.
We want to jump on this weakness to put money to work.
Nothing has changed with fundamentals, so 'good names' have gone on sale.
Jim Cramer explains how to rely on long-term themes to take advantage of this market's wild action.
Down days for the markets are great buying opportunities if you're prepared.
With volatility likely to increase, we are putting Darden Restaurants, Nordstrom and Valley National Bancorp in the Bullpen.
So far this morning RTN is working higher and could even make a new high close.
Donald Trump simply gave stock market participants exactly what they wanted.
Our trades today were about broader rebalancing and ensuring that we have plenty of ammo available for potential moves.
You might actually be grateful that stocks took one on the jaw on Monday.
You mean to tell me if the buyers walked away for 10 minutes they couldn't get these stocks lower?
With the price of RTN $25 higher than last month we need to reexamine our charts and indicators.
Jim discusses an analyst upgrade of Allergan, the super cycle concerns of Apple and how it impacts Broadcom, defense names in the bullpen, and a busy week of earnings.
There probably will not be a trade war, beyond the intention of making a point.
Stocks of companies that go hand and hand with an economic expansion just won't quit.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.